ARYA SCIENCES ACQU CORP IV's ticker is ARYD and the CUSIP is G31659108. A total of 26 filers reported holding ARYA SCIENCES ACQU CORP IV in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,010 | -99.9% | 100,000 | 0.0% | 0.49% | -28.8% |
| Q3 2022 | $999,000 | +1.8% | 100,000 | 0.0% | 0.69% | -9.7% |
| Q2 2022 | $981,000 | +0.1% | 100,000 | 0.0% | 0.76% | +26.8% |
| Q1 2022 | $980,000 | -1.2% | 100,000 | 0.0% | 0.60% | +164.3% |
| Q4 2021 | $992,000 | +56.7% | 100,000 | +58.7% | 0.23% | -56.9% |
| Q3 2021 | $633,000 | -31.9% | 62,997 | -27.4% | 0.53% | -18.9% |
| Q2 2021 | $930,000 | +77.5% | 86,730 | +73.5% | 0.65% | +388.7% |
| Q1 2021 | $524,000 | – | 50,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 700,000 | $7,331,000 | 2.49% |
| Soleus Capital Management, L.P. | 300,000 | $3,142,000 | 0.57% |
| HealthCor Management, L.P. | 1,159,360 | $12,141,000 | 0.43% |
| Bain Capital Life Sciences Investors, LLC | 700,000 | $7,331,000 | 0.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $5,200,000 | 0.40% |
| Boxer Capital, LLC | 750,000 | $10,335,000 | 0.35% |
| Union Square Park Capital Management, LLC | 100,500 | $1,052,000 | 0.35% |
| Altium Capital Management LP | 100,000 | $1,047,000 | 0.29% |
| Consonance Capital Management LP | 250,000 | $2,618,000 | 0.28% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,000,000 | $10,473,000 | 0.23% |